Financial Research Report
ACADIA Pharmaceuticals Inc.
FIN 534
Name
Instructor
Date

ACADIA Pharmaceuticals Inc. Financial Research Report 1.0. Introduction
Pharmaceuticals Inc. is a publicly traded company in the United States of America in the biopharmaceutical industry. The company is devoted to discover, develop, and commercialize small molecule drugs that are useful in treating disorders in the central nervous system. The current engagement of the company is in treatment of induced dysfunction in Parkinson's disease, schizophrenia, neuropathic pain and glaucoma. All company product candidates are a product of discoveries made at the company’s discovery platform. There is a strong team with industry experience which is put in place to aid in the development of these products. This team work together with the company’s world-class scientific and clinical advisors who are also hired by the company. It was found in 1993 and has it’s headquarter situated in San Diego, in California. The aim of this paper is to evaluate the performance of the company using ratio and stock price analysis. The financial statements for the year ending 31st December 2012, 2011, and 2010 will be used in this analysis. These are complete financial statements covering the whole financial statements retrieved from yahoo finance. 2.0. Rationale for choosing the company for which to invest
This company was selected because of interesting trend in the industry. For the past three years, from 2010 to 2012, the company has experienced an interesting trend, recording a poor performance in 2011 and 2012 but positive results in 2010. The company is one of the best performing in the pharmaceutical industry and its dealing with biopharmaceutical products makes it an interesting one to study in the industry. 3.0. Ratio analysis
The ratio analysis is uses in financial analysis